Immatics IMTX
NASDAQ IMTX
$8.44 -0.34 (-3.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immatics (IMTX) Long-Term Debt Repayments (2022 - 2023)

Updated

Immatics (IMTX) recorded Long-Term Debt Repayments of -$3.34 million in FY2025, compared with -$2.18 million in FY2024.

Analysis

Immatics (IMTX) Long-Term Debt Repayments (2022 - 2023) Analysis & Trends

Starting with FY2020, Immatics' Long-Term Debt Repayments history includes 6 years.

  • Annual Long-Term Debt Repayments has ranged from -$4.16 million in FY2023 to -$2.18 million in FY2024 over the past five years.
  • Per Business Quant data, IMTX's Long-Term Debt Repayments was -$2.18 million in FY2024, -$4.16 million in FY2023, -$3 million in FY2022 and -$3.2 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immatics 1.18 Bn -861.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1.05 Mn
Sep 30, 2023 -1.10 Mn
Jun 30, 2023 -1.09 Mn
Mar 31, 2023 -929,514.02
Dec 31, 2022 -694,788.46
Sep 30, 2022 -774,354.69
Jun 30, 2022 -752,274.97
Mar 31, 2022 -773,290.69
API Access

Immatics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=IMTX&period=max&api_key=YOUR_API_KEY